APO-GUANFACINE XR 2 MG
GUANFACINE (GUANFACINE HYDROCHLORIDE) : 2 MG · DIN 02523736 · APOTEX INC
Health Canada status: MARKETED
What is APO-GUANFACINE XR?
APO-GUANFACINE XR 2 MG contains GUANFACINE (GUANFACINE HYDROCHLORIDE) : 2 MG. It is listed in the Health Canada Drug Product Database under DIN 02523736, held by APOTEX INC, supplied as TABLET (EXTENDED-RELEASE) for ORAL administration. Health Canada currently lists it as marketed, status dated 31-Jan-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is APO-GUANFACINE XR used for?
APO-GUANFACINE XR (guanfacine extended-release tablets) is indicated as monotherapy for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17 years. APO-GUANFACINE XR is also indicated as adjunctive therapy to psychostimulants for the treatment of ADHD in children and adolescents, aged 6 to 17 years, with a sub-optimal response to psychostimulants.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02523736 |
|---|---|
| Brand name | APO-GUANFACINE XR |
| Generic / active ingredient | GUANFACINE (GUANFACINE HYDROCHLORIDE) : 2 MG |
| Manufacturer | APOTEX INC |
| Strength | 2 MG |
| Dosage form | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C02AC02 GUANFACINE |
| AHFS class | 24:08.16 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 31-Jan-2022 |
| Original market date | 2022-01-31 00:00:00 |
How is it stored and handled?
null
How is it supplied?
Bottles of 100 for 1 mg, 2 mg, 3 mg, and 4 mg tablets
What can be used instead?
Other Canadian products sharing ATC code C02AC02 GUANFACINE. 19 of 19 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AG-GUANFACINE XR | 1 MG | TABLET (EXTENDED-RELEASE) | ANGITA PHARMA INC. | MARKETED | DIN 02525127 |
| AG-GUANFACINE XR | 2 MG | TABLET (EXTENDED-RELEASE) | ANGITA PHARMA INC. | MARKETED | DIN 02525135 |
| AG-GUANFACINE XR | 3 MG | TABLET (EXTENDED-RELEASE) | ANGITA PHARMA INC. | MARKETED | DIN 02525143 |
| AG-GUANFACINE XR | 4 MG | TABLET (EXTENDED-RELEASE) | ANGITA PHARMA INC. | MARKETED | DIN 02525151 |
| APO-GUANFACINE XR | 1 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | DIN 02523728 |
| APO-GUANFACINE XR | 3 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | DIN 02523744 |
| APO-GUANFACINE XR | 4 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | DIN 02523752 |
| INTUNIV XR | 1 MG | TABLET (EXTENDED-RELEASE) | TAKEDA CANADA INC | MARKETED | DIN 02409100 |
| INTUNIV XR | 2 MG | TABLET (EXTENDED-RELEASE) | TAKEDA CANADA INC | MARKETED | DIN 02409119 |
| INTUNIV XR | 3 MG | TABLET (EXTENDED-RELEASE) | TAKEDA CANADA INC | MARKETED | DIN 02409127 |
Who else supplies GUANFACINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. GUANFACINE appears in 61 registered pack listings across 5 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.